This page includes the latest FDA filings for Ridgeback Biotherapeutics L P. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Ridgeback Biotherapeutics, LP | Prescription Medication | 2025-02-12 |
Ridgeback Biotherapeutics, LP | Prescription Medication | 2022-05-24 |
Ridgeback Biotherapeutics, LP | Prescription Medication | 2021-12-21 |
Ridgeback Biotherapeutics, LP | Prescription Medication | 2021-01-05 |
Ridgeback Biotherapeutics, LP | EBANGA | 2020-12-21 |
NCAGE Code | 8B1C9 | RIDGEBACK BIOTHERAPEUTICS L.P. |
CAGE Code | 8B1C9 | RIDGEBACK BIOTHERAPEUTICS L.P. |
S.A.M. Registration | 8B1C9 [116921498] | RIDGEBACK BIOTHERAPEUTICS L.P. |